Thriva, a London-based platform providing mail-order blood tests for consumers, has raised another $7.3 million in backing thanks to a new Series A round. Pembroke VCT and Guinness Asset Management were among the round’s participants, which brought the company’s total funds raised to $8.2 million.
WHAT THEY DO
Since 2016, Thriva has offered mail-order tests and results interpretations to more...
Nurx, the San Francisco-based startup best known for providing contraceptives via telemedicine, has just added a new home STI testing option to its slew of services.
The new offerings, which were first spotted by TechCrunch, will allow potential clients to fill out an online questionnaire to receive an STI test kit in the mail. The kit comes with instructions and tools.
There are three STI...
